We then performed studies in ERα + breast cancer cells selected on the basis of ZNF423 SNP genotypes, and confirmed those results in clustered, regularly interspaced short palindromic repeats (CRISPR)-engineered ZR75-1 breast cancer cells with different ZNF423 SNP genotypes. The gene discussed is ZNF423; the disease is breast cancer.